The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies

por Persson, Mika L, Douglas, Alicia M, Alvaro, Frank, Faridi, Pouya, Larsen, Martin R, Alonso, Marta M, Vitanza, Nicholas A, Dun, Matthew D
Publicado 2022

Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

por Foster, Jessica B., Alonso, Marta M., Sayour, Elias, Davidson, Tom B., Persson, Mika L., Dun, Matthew D., Kline, Cassie, Mueller, Sabine, Vitanza, Nicholas A., van der Lugt, Jasper
Publicado 2023

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers

por McLachlan, Tabitha, Matthews, William C., Jackson, Evangeline R., Staudt, Dilana E., Douglas, Alicia M., Findlay, Izac J., Persson, Mika L., Duchatel, Ryan J., Mannan, Abdul, Germon, Zacary P., Dun, Matthew D.
Publicado 2022

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

por Jackson, Evangeline R., Duchatel, Ryan J., Staudt, Dilana E., Persson, Mika L., Mannan, Abdul, Yadavilli, Sridevi, Parackal, Sarah, Game, Shaye, Chong, Wai Chin, Jayasekara, W. Samantha N., Grand, Marion Le, Kearney, Padraic S., Douglas, Alicia M., Findlay, Izac J., Germon, Zacary P., McEwen, Holly P., Beitaki, Tyrone S., Patabendige, Adjanie, Skerrett-Byrne, David A., Nixon, Brett, Smith, Nathan D., Day, Bryan, Manoharan, Neevika, Nagabushan, Sumanth, Hansford, Jordan R., Govender, Dinisha, McCowage, Geoff B., Firestein, Ron, Howlett, Meegan, Endersby, Raelene, Gottardo, Nicholas G., Alvaro, Frank, Waszak, Sebastian M., Larsen, Martin R., Colino-Sanguino, Yolanda, Valdes-Mora, Fatima, Rakotomalala, Andria, Meignan, Samuel, Pasquier, Eddy, André, Nicolas, Hulleman, Esther, Eisenstat, David D., Vitanza, Nicholas A., Nazarian, Javad, Koschmann, Carl, Mueller, Sabine, Cain, Jason E., Dun, Matthew D.
Publicado 2023